Journal of Pediatric Neurology 2024; 22(03): 208-214
DOI: 10.1055/s-0043-1770080
Original Article

Effects of Hemogram Parameters on Remission Durations in Self-Limited Epilepsy with Centrotemporal Spikes

1   Department of Pediatric Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
,
1   Department of Pediatric Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
,
1   Department of Pediatric Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
,
1   Department of Pediatric Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
,
1   Department of Pediatric Neurology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey
› Institutsangaben

Abstract

The hemogram parameters have been extensively discussed in numerous diseases, including epilepsy, for their diagnostic and prognostic values. We aimed to investigate the impact of hemogram parameters, namely, the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) at the time of the first seizure on the remission durations of the patients with self-limited epilepsy with centrotemporal spikes (SeLECTS). This retrospective study was conducted on patients with SeLECTS with a minimum follow-up of 2 years. We assessed the hemogram parameters obtained from the venous blood samples collected from the patients upon admission. The duration of remission was categorized into two groups for further data analysis: those with a remission period less than 2 years and those with a remission period of more than 2 years. This study involved 122 patients with SeLECTS, of which 85% (n = 102) had remission durations of ≤2 years. The analysis revealed that patients with remission durations exceeding 2 years had a significantly higher median leukocyte (p = 0.009), neutrophil (p < 0.001), and platelet (p < 0.001) counts. Additionally, higher levels of NLR and PLR were observed in patients with longer-term remission (p < 0.001). However, there were no significant differences between the two groups in terms of lymphocyte count, monocyte count, mean platelet volume, or LMR. Leukocyte, neutrophil, platelet, NLR, and PLR counts have shown potential as predictive indicators of remission times in patients with SeLECTS. Neurologists can potentially find value in these easily accessible parameters when evaluating the future trajectory of patients with SeLECTS.

Authors' Contributions

All the authors have made substantial contributions to the creation of the concept, literature search, writing and editing of the manuscript, analyses, and evaluation of the results. ÇG has been primarily involved in acquisition of the data. All the authors have seen the final version and given their consent for publication.




Publikationsverlauf

Eingereicht: 17. April 2023

Angenommen: 15. Mai 2023

Artikel online veröffentlicht:
19. Juni 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Dey A, Kang X, Qiu J, Du Y, Jiang J. Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci 2016; 37 (06) 463-484
  • 2 Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7 (01) 31-40
  • 3 Aziz N. Measurement of circulating cytokines and immune-activation markers by multiplex technology in the clinical setting: what are we really measuring?. For Immunopathol Dis Therap 2015; 6 (1–2): 19-22
  • 4 Huang Y, Ying Z, Quan W. et al. The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barré syndrome. Int J Neurosci 2018; 128 (08) 729-735
  • 5 Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M. Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci 2018; 387: 115-118
  • 6 Tahto E, Jadric R, Pojskic L, Kicic E. Neutrophil-to-lymphocyte ratio and its relation with markers of inflammation and myocardial necrosis in patients with acute coronary syndrome. Med Arch (Sarajevo, Bosnia Herzegovina) 2017; 71 (05) 312-315
  • 7 Yang D-H, Qian M-Z, Wei M-M. et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget 2017; 8 (44) 76099-76107
  • 8 Güneş M, Büyükgöl H. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation. Int J Neurosci 2020; 130 (11) 1095-1100
  • 9 Özdemir HH, Akil E, Acar A. et al. Changes in serum albumin levels and neutrophil-lymphocyte ratio in patients with convulsive status epilepticus. Int J Neurosci 2017; 127 (05) 417-420
  • 10 Goksugur SB, Kabakus N, Bekdas M, Demircioglu F. Neutrophil-to-lymphocyte ratio and red blood cell distribution width is a practical predictor for differentiation of febrile seizure types. Eur Rev Med Pharmacol Sci 2014; 18 (22) 3380-3385
  • 11 Yigit Y, Yilmaz S, Akdogan A, Halhalli HC, Ozbek AE, Gencer EG. The role of neutrophil-lymphocyte ratio and red blood cell distribution width in the classification of febrile seizures. Eur Rev Med Pharmacol Sci 2017; 21 (03) 554-559
  • 12 Morkavuk G, Koc G, Leventoglu A. Is the differential diagnosis of epilepsy and psychogenic nonepileptic seizures possible by assessing the neutrophil/lymphocyte ratio?. Epilepsy Behav 2021; 116: 107736
  • 13 Zhou W, Kuang T, Han X. et al. Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms. Endocr Connect 2020; 9 (04) 289-298
  • 14 Tham T, Olson C, Khaymovich J, Herman SW, Costantino PD. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 2018; 275 (07) 1663-1670
  • 15 Yokota M, Katoh H, Nishimiya H. et al. Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid cancer. J Surg Res 2020; 246: 535-543
  • 16 Kramer U. Atypical presentations of benign childhood epilepsy with centrotemporal spikes: a review. J Child Neurol 2008; 23 (07) 785-790
  • 17 Loiseau P, Duché B, Cordova S, Dartigues JF, Cohadon S. Prognosis of benign childhood epilepsy with centrotemporal spikes: a follow-up study of 168 patients. Epilepsia 1988; 29 (03) 229-235
  • 18 Peters JM, Camfield CS, Camfield PR. Population study of benign rolandic epilepsy: is treatment needed?. Neurology 2001; 57 (03) 537-539
  • 19 Shakeri M, Datta AN, Malfait D. et al. Sub-cortical brain morphometry and its relationship with cognition in rolandic epilepsy. Epilepsy Res 2017; 138: 39-45
  • 20 Garcia-Ramos C, Jackson DC, Lin JJ. et al. Cognition and brain development in children with benign epilepsy with centrotemporal spikes. Epilepsia 2015; 56 (10) 1615-1622
  • 21 Xiao F, Lei D, An D. et al. Functional brain connectome and sensorimotor networks in rolandic epilepsy. Epilepsy Res 2015; 113: 113-125
  • 22 Vannest J, Tenney JR, Gelineau-Morel R, Maloney T, Glauser TA. Cognitive and behavioral outcomes in benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2015; 45: 85-91
  • 23 He W, Liu H, Liu Z, Wu Q. Electrical status epilepticus in sleep affects intrinsically connected networks in patients with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2020; 106: 107032
  • 24 Doumlele K, Friedman D, Buchhalter J, Donner EJ, Louik J, Devinsky O. Sudden unexpected death in epilepsy among patients with benign childhood epilepsy with centrotemporal spikes. JAMA Neurol 2017; 74 (06) 645-649
  • 25 Smith AB, Bajomo O, Pal DK. A meta-analysis of literacy and language in children with rolandic epilepsy. Dev Med Child Neurol 2015; 57 (11) 1019-1026
  • 26 Vago C, Bulgheroni S, Franceschetti S, Usilla A, Riva D. Memory performance on the California Verbal Learning Test of children with benign childhood epilepsy with centrotemporal spikes. Epilepsy Behav 2008; 13 (04) 600-606
  • 27 Specchio N, Wirrell EC, Scheffer IE. et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions. Epilepsia 2022; 63 (06) 1398-1442
  • 28 Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry 2017; 8: 228
  • 29 Leffa DT, Torres ILS, Rohde LA. A review on the role of inflammation in attention-deficit/hyperactivity disorder. Neuroimmunomodulation 2018; 25 (5–6): 328-333
  • 30 Takahashi N, Ishizuka K, Inada T. Peripheral biomarkers of attention-deficit hyperactivity disorder: current status and future perspective. J Psychiatr Res 2021; 137: 465-470
  • 31 Lanzkowsky P, Lipton JM, Fish JD. eds. Appendix 1: hematological reference values. In: Lanzkowsky's Manual of Pediatric Hematology and Oncology. 6th ed.. San Diego, CA: Academic Press; 2016: 709-728
  • 32 Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39 (02) 175-191
  • 33 Bazhanova ED, Kozlov AA, Litovchenko AV. Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation. A literature review. Brain Sci 2021; 11 (05) 663
  • 34 Zahorec R. Ratio of neutrophil to lymphocyte counts: rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102 (01) 5-14
  • 35 Giede-Jeppe A, Bobinger T, Gerner ST. et al. Neutrophil-to-lymphocyte ratio is an independent predictor for in-hospital mortality in spontaneous intracerebral hemorrhage. Cerebrovasc Dis 2017; 44 (1–2): 26-34
  • 36 Shah AK, Shein N, Fuerst D, Yangala R, Shah J, Watson C. Peripheral WBC count and serum prolactin level in various seizure types and nonepileptic events. Epilepsia 2001; 42 (11) 1472-1475
  • 37 Gunes M. Investigating neutrophil-to-eosinophil ratio and variations in eosinophil levels in epilepsy patients with generalized tonic-clonic seizures. Ann Med Res 2020; 27 (07) 1930-1933
  • 38 Li Y, Matzka L, Flahive J, Weber D. Potential use of leukocytosis and anion gap elevation in differentiating psychogenic nonepileptic seizures from epileptic seizures. Epilepsia Open 2019; 4 (01) 210-215
  • 39 Simon RP. Physiologic consequences of status epilepticus. Epilepsia 1985; 26 (Suppl. 01) S58-S66
  • 40 Hughes JR. Benign epilepsy of childhood with centrotemporal spikes (BECTS): to treat or not to treat, that is the question. Epilepsy Behav 2010; 19 (03) 197-203
  • 41 Zhao M, Tuo H, Wang S, Zhao L. The roles of monocyte and monocyte-derived macrophages in common brain disorders. BioMed Res Int 2020; 2020: 9396021
  • 42 Sarkis RA, Jehi L, Silveira D, Janigro D, Najm I. Patients with generalised epilepsy have a higher white blood cell count than patients with focal epilepsy. Epileptic Disord 2012; 14 (01) 57-63
  • 43 Nowak M, Bauer S, Haag A. et al. Interictal alterations of cytokines and leukocytes in patients with active epilepsy. Brain Behav Immun 2011; 25 (03) 423-428
  • 44 Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm 2019; 2019: 9213074
  • 45 Dilber B, Reis GP, Kolayli CC, Cansu A. The role of neutrophil-to-lymphocyte ratio, red blood cell distribution width, and mean platelet volume in predicting febrile seizures and differentiating febrile seizure types. J Pediatr Epilepsy 2022; 11 (01) 004-014
  • 46 Hanci F, Dincel GK, Bekdas M, Yoldas MA. The predictive role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in children with simple febrile seizures. Exp Biomed Res 2021; 4 (03) 198-205
  • 47 Kurniawan A, Lainama MS, Diarsvitri W. Mean platelet ratio, neutrophil to lymphocyte ratio, and the risk of febrile seizures in children aged 6–59 months. Open Access Maced J Med Sci 2021; 9 (B): 276-280
  • 48 Singh J, Thakur G, Alexander J. et al. Predictors of nonconvulsive seizure and their effect on short-term outcome. J Clin Neurophysiol 2021; 38 (03) 221-225